Indications And Dose
Hyperchloraemic acidosis associated with potassium deficiency (as in some renal tubular and gastro- intestinal disorders) ▶BY MOUTH ▶Adult: (consult product literature)
PDF page 1141
Loading InternPractice…
Drug reference
Hyperchloraemic acidosis associated with potassium deficiency (as in some renal tubular and gastro- intestinal disorders) ▶BY MOUTH ▶Adult: (consult product literature)
PDF page 1141
Hypochloraemia. plasma- potassium concentration above 5 mmol/litre
PDF page 1141
Cardiac disease. elderly
PDF page 1141
These tablets do not contain chloride.
PDF page 1141
Diarrhoea. flatulence. gastrointestinal discomfort. nausea. vomiting
PDF page 1141
Avoid in severe impairment. Monitoring Close monitoring required in renal impairment—high risk of hyperkalaemia.
PDF page 1141
To be dissolved in water before administration.
PDF page 1141
There can be variation in the licensing of different medicines containing the same drug. Effervescent tablet CAUTIONARY AND ADVISORY LABELS 13, 21 ▶Potassium bicarbonate with potassium acid tartrate (Non- proprietary) Potassium acid tartrate 300 mg, Potassium bicarbonate 500 mg Potassium (potassium 6.5mmol) effervescent tablets BPC 1968 | 56 tablet G £91.66–£92.15 DT = £92.15
PDF page 1141
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1141